Status:
TERMINATED
Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial
Lead Sponsor:
Essentia Health
Conditions:
Rosacea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rosacea is a common chronic dermatological condition, characterized by recurrent or persistent redness, permanent dilation of small blood vessel causing small red lesions, and papules/pustules. The si...
Detailed Description
Rosacea is a common chronic dermatological condition. The epidemiology of rosacea has not been determined extensively, due to part in problems with case definition. Rosacea is usually described as bei...
Eligibility Criteria
Inclusion
- Diagnosis of facial rosacea made or confirmed by one of the investigators.
- Severity of signs of rosacea "greater than mild" at the time of enrollment.
Exclusion
- Treatment for rosacea during the 3 months prior to enrollment.
- Use of zinc dietary supplement \> 25 mg per day during the 3 months prior to enrollment ( Most patients taking multivitamins with Zinc, often 15 mg per day, will not be excluded, whereas most patients taking additional Zinc supplements, often 25-50 mg per day or more will be excluded.)
- Diagnosis of rosacea fulminancy.
- Pregnant or breast feeding.
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT00395226
Start Date
July 1 2006
End Date
July 1 2008
Last Update
June 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Mary's Duluth Clinic Health System
Duluth, Minnesota, United States, 55805